M 66 (Meloxicam 7.5 mg)

Pill imprint M 66 has been identified as Meloxicam 7.5 mg.

Meloxicam is used in the treatment of inflammatory conditions; osteoarthritis; fibromyalgia; rheumatoid arthritis; tendonitis (and more), and belongs to the drug class nonsteroidal anti-inflammatory agents. Prior to 30 weeks gestation: Risk cannot be ruled out during pregnancy. Starting at 30 weeks gestation: There is positive evidence of human fetal risk during pregnancy. Meloxicam 7.5 mg is not subject to the Controlled Substances Act.

See also related documents.

Meloxicam 7.5 mg M 66
Meloxicam 7.5 mg M 66
Meloxicam 7.5 mg M 66
Meloxicam
Imprint:
M 66
Strength:
7.5 mg
Color:
Yellow
Size:
6.00 mm
Shape:
Round
Availability:
Prescription only
Drug Class:
Nonsteroidal anti-inflammatory agents
Pregnancy Category:
C - Risk cannot be ruled out - prior to 30 weeks gestation
D - Positive evidence of risk - starting at 30 weeks gestation
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Mylan Pharmaceuticals Inc.
National Drug Code (NDC):
00378-1066
Inactive Ingredients:
silicon dioxide
crospovidone
lactose monohydrate
magnesium stearate
microcrystalline cellulose
sodium lauryl sulfate
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
51079-0457 UDL Laboratories Inc
18837-0239 Innoviant Pharmacy Inc (repackager)

Note: Inactive ingredients may vary.

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2015 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web1)